Abnormal Involuntary Movement Scale (AIMS) and Extrapyramidal Symptom Rating Scale (ESRS): cross-scale comparison in assessing tardive dyskinesia
- PMID: 15913963
- DOI: 10.1016/j.schres.2005.03.008
Abnormal Involuntary Movement Scale (AIMS) and Extrapyramidal Symptom Rating Scale (ESRS): cross-scale comparison in assessing tardive dyskinesia
Abstract
Assessing tardive dyskinesia (TD) has been complicated by the use of different research criteria and rating scales. We studied concordance between two commonly used scales, the Abnormal Involuntary Movement Scale (AIMS) and Extrapyramidal Symptom Rating Scale (ESRS), to study interscale concordance and criteria to define TD. Patients with schizophrenia or schizoaffective disorder (N = 374) were rated at baseline with both scales. Linear and logistic regression models explored relationships between scale ratings and mapped scores for corresponding items. TD was defined as at least mild in > or = 2 anatomical areas, or moderate or greater symptoms in > or = 1 area at baseline. Logistic regression was used to find simplified criteria for predicting AIMS-defined TD by ESRS scores. There was a strong association on corresponding item ratings. "Mild" was defined as AIMS score of 2 and ESRS 2 or 3, and "moderate or greater" as AIMS score > or = 3 and ESRS > or = 4. Using these criteria, there was 96.0% (359/374) agreement between AIMS- and ESRS-defined TD cases. The ESRS Clinical Global Impressions of severity of dyskinesia (CGI-SD) best predicted AIMS-defined TD. An ESRS CGI-SD > or = 4 (95% CI: 3.61, 4.76) was associated with > or = 95% probability of AIMS-defined TD. High concordance between the scales for dyskinesia scores was found. Findings suggest that the ESRS CGI-SD score can serve as a simplified criterion for identifying AIMS-defined TD, and may be a useful tool for future research-based TD analyses, when occurring in the context of a full movement disorder assessment.
Similar articles
-
An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term study.Schizophr Res. 2005 Sep 15;77(2-3):129-39. doi: 10.1016/j.schres.2005.03.015. Schizophr Res. 2005. PMID: 15913962 Clinical Trial.
-
Manual for the Extrapyramidal Symptom Rating Scale (ESRS).Schizophr Res. 2005 Jul 15;76(2-3):247-65. doi: 10.1016/j.schres.2005.02.013. Epub 2005 Apr 18. Schizophr Res. 2005. PMID: 15949657
-
The Extrapyramidal Symptom Rating Scale and Its Abbreviated Version: A Critical Review of Clinimetric Properties.Psychother Psychosom. 2023;92(6):359-366. doi: 10.1159/000535113. Epub 2023 Dec 7. Psychother Psychosom. 2023. PMID: 38061344 Review.
-
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder.Psychopharmacol Bull. 2017 Aug 1;47(3):69-76. Psychopharmacol Bull. 2017. PMID: 28839342 Free PMC article. Clinical Trial.
-
A critical review of rating scales in the assessment of movement disorders in schizophrenia.Curr Drug Targets. 2006 Sep;7(9):1225-9. doi: 10.2174/138945006778226589. Curr Drug Targets. 2006. PMID: 17017898 Review.
Cited by
-
Impact of a pharmacist-driven tardive dyskinesia screening service.Ment Health Clin. 2021 Jul 16;11(4):248-253. doi: 10.9740/mhc.2021.07.248. eCollection 2021 Jul. Ment Health Clin. 2021. PMID: 34316421 Free PMC article.
-
Handwriting analysis indicates spontaneous dyskinesias in neuroleptic naïve adolescents at high risk for psychosis.J Vis Exp. 2013 Nov 21;(81):e50852. doi: 10.3791/50852. J Vis Exp. 2013. PMID: 24300590 Free PMC article.
-
Studying the functional connectivity of the primary motor cortex with the binarized cross recurrence plot: The influence of Parkinson's disease.PLoS One. 2021 Jun 7;16(6):e0252565. doi: 10.1371/journal.pone.0252565. eCollection 2021. PLoS One. 2021. PMID: 34097691 Free PMC article.
-
Influence of ANKK1 and DRD2 polymorphisms in response to haloperidol.Eur Arch Psychiatry Clin Neurosci. 2013 Feb;263(1):65-74. doi: 10.1007/s00406-012-0348-1. Epub 2012 Aug 15. Eur Arch Psychiatry Clin Neurosci. 2013. PMID: 22893251 Clinical Trial.
-
Blood Flow and Glucose Metabolism Dissociation in the Putamen Is Predictive of Levodopa Induced Dyskinesia in Parkinson's Disease Patients.Front Neurol. 2019 Nov 21;10:1217. doi: 10.3389/fneur.2019.01217. eCollection 2019. Front Neurol. 2019. PMID: 31824400 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical